news alert

Vanda Pharmaceuticals to Announce Third Quarter 2022 Financial Results on November 2, 2022


Vanda Pharmaceuticals Inc. (Vanda) (Nasdaq: VNDA) announced it will release results for the third quarter 2022 on Wednesday, November 2, 2022, after the market closes.  

Vanda will host a conference call at 4:30 PM ET on Wednesday, November 2, 2022, during which management will discuss the third quarter 2022 financial results and other corporate activities. To participate in the conference call, please dial 1-800-715-9871 (domestic) or 1-646-307-1963 (international) and use passcode 5456289.

The conference call will be broadcast simultaneously and archived on Vanda’s website, Investors should go to the website at least 15 minutes early to register, download, and install any necessary audio software.

A replay of the call will be available on Wednesday, November 2, 2022, beginning at 8:30 PM ET and will be accessible until Wednesday, November 9, 2022, at 8:30 PM ET. The replay call-in number is 1-800-770-2030 for domestic callers and 1-609-800-9909 for international callers. The passcode number is 5456289.

About Vanda Pharmaceuticals Inc.

Vanda is a leading global biopharmaceutical company focused on the development and commercialization of innovative therapies to address high unmet medical needs and improve the lives of patients. For more on Vanda Pharmaceuticals Inc., please visit and follow us on Twitter @vandapharma.

Leave a Reply

Your email address will not be published. Required fields are marked *